publication date: Dec. 20, 2010

In this issue: 

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

In Brief: ASCO awards career development grants.

Funding Opportunities listed.

Download (PDF 341KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.